Regulators of Mineralization and Long‐Term Progression of Aortic Valve and Mitral Annular Calcification: MESA
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.042370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Anna E Bortnick und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology Montefiore Medical Center and Albert Einstein College of Medicine Bronx NY USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Calcium-Binding Proteins, Calcinosis, Extracellular Matrix Proteins. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Aortic valve calcification (AVC) and mitral annual calcification (MAC) may progress to aortic and mitral stenosis in older adults. The role of major mineralization regulators MGP (matrix Gla protein), FGF‐23 (fibroblast growth factor‐23), and fetuin‐A in long‐term progression of AVC and MAC remains unexamined.
Methods
We measured blood levels of dp‐ucMGP (n=2663) at study baseline and evaluated these concurrently with prior baseline measures of FGF‐23 (n=6547) and fetuin‐A (n=2550) in relation to AVC and MAC quantified on ≤3 serial computed tomography scans over 9.4 (interquartile range, 9.0–9.8) years in MESA (Multi‐Ethnic Study of Atherosclerosis). We used linear mixed‐effects models to simultaneously assess the incidence and progression of AVC and MAC.
Results
Our objective was to investigate the association of circulating dephosphorylated–uncarboxylated (dp‐uc) MGP, reflecting vitamin K deficiency/diminished MGP anticalcific capacity; FGF‐23, a phosphaturic hormone; and fetuin‐A, a calcium‐phosphate solubilizer, with long‐term incidence and progression of AVC and MAC. After adjustment for demographic and clinical characteristics, dp‐ucMGP was associated with higher annual incidence/progression of AVC (0.94 [95% CI, 0.42, 1.46] Agatston units/y) and MAC (3.90 [95% CI, 1.06, 6.74] Agatston units/y); FGF‐23 with higher annual incidence/progression of MAC (2.61 [95% CI, 0.50, 4.72] Agatston units/y); and fetuin‐A with lower annual incidence/progression of AVC (−0.89 [95% CI, −1.55, −0.23] Agatston units/y (all per SD increment in regulator).
Conclusions
In this multiethnic sample, dp‐ucMGP and FGF‐23 were associated with higher, and fetuin‐A with lower, long‐term incidence/progression of valvular or annular calcification. This has implications for therapeutic trials of calcific valvular disease, particularly targeting vitamin K supplementation to individuals with higher dp‐ucMGP levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology Montefiore Medical Center and Albert Einstein College of Medicine Bronx NY USA.
- Division of Geriatrics and Department of OB/GYN and Women's Health Montefiore Medical Center and Albert Einstein College of Medicine Bronx NY USA.
- Cardiology Section, San Francisco Veterans Administration Health Care System San Francisco CA USA.
- Department of Medicine, Epidemiology and Biostatistics University of California San Francisco San Francisco CA USA.
- Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) and the Vitamin K Team, Tufts University Boston MA USA.
- Kidney Research Institute, Division of Nephrology, Department of Medicine University of Washington Seattle WA USA.
ORCID-Profile: Anna E Bortnick, Mahim Naveed, Xueyan Fu, Ian de Boer, Joachim H Ix, Ryung Kim, Rohan Kankaria, Russell P Tracy, Michael Tsai, Matthew Budoff, George Thanassoulis, Sarah Booth, Jorge R Kizer
Förderung
- NHLBI NIH HHS
- NCRR NIH HHS
- NCATS NIH HHS
Zitieren
APA
Bortnick, A. E., Naveed, M., Fu, X., Shea, K., Kestenbaum, B., de Boer, I., Ix, J. H., Kim, R., Hamerton, E., Kankaria, R., Tracy, R. P., Tsai, M., Budoff, M., Thanassoulis, G., Booth, S., & Kizer, J. R. (2026). Regulators of Mineralization and Long‐Term Progression of Aortic Valve and Mitral Annular Calcification: MESA. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042370
Vancouver
Bortnick AE, Naveed M, Fu X, Shea K, Kestenbaum B, de Boer I, et al. Regulators of Mineralization and Long‐Term Progression of Aortic Valve and Mitral Annular Calcification: MESA. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.042370
BibTeX
@article{Bortnick2026,
author = {Bortnick, Anna E and Naveed, Mahim and Fu, Xueyan and Shea, Kyla and Kestenbaum, Bryan and de Boer, Ian and Ix, Joachim H and Kim, Ryung and Hamerton, Emily and Kankaria, Rohan and Tracy, Russell P and Tsai, Michael and Budoff, Matthew and Thanassoulis, George and Booth, Sarah and Kizer, Jorge R},
title = {Regulators of Mineralization and Long‐Term Progression of Aortic Valve and Mitral Annular Calcification: MESA},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.042370}
}
EUVIMED